NCT06591260View on ClinicalTrials.gov

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions
MyocarditisVentricular ArrhythmiaInflammatory CardiomyopathyGenetic PredispositionAutoimmunityArrhythmiaCardiomyopathiesImmunosuppresionCatheter Ablation
Interventions
OTHER

support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation

Treatment will be patient-tailored, integrating international guidelines recommendation and the experience of the center where enrollment takes place.

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

Scientific Institute San Raffaele

OTHER

NCT06591260 - Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED) | Biotech Hunter | Biotech Hunter